ARTICLE | Company News
NuView Radiopharmaceuticals Inc., University of Southern California deal
March 10, 2008 7:00 AM UTC
NuView received exclusive rights to develop and commercialize the university's F-18 FXA to diagnose cardiac disease. F-18 FXA is a fluorine-18 radiolabeled adenosine derivative that is in preclinical ...